JPMorgan Chase & Co. restated their neutral rating on shares of GlaxoSmithKline (LON:GSK) in a research note issued to investors on Monday, AnalystRatings.NET reports. JPMorgan Chase & Co. has also taken action a number of other stocks recently. The firm lowered its price target on shares of Transocean from $60.00 to $54.00. Also, JPMorgan Chase […]
GlaxoSmithKline Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK) is a post from: Zolmax
The post GlaxoSmithKline Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK) appeared first on Zolmax.